AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Atezolizumab in South Africa
2 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TECENTRIQ 1 200 mg | 54/30.1/0061 | Roche Products (Pty) Ltd | active | 29 Sept 2025 |
| TECENTRIQ 840 mg | 54/30.1/0060 | Roche Products (Pty) Ltd | active | 1 Jan 1900 |
Atezolizumab — SAHPRA Registration Details
SAHPRA (South Africa) has 2 registered products containing Atezolizumab, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Atezolizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.